Adrenomedullin induces direct (endothelium-independent) vasorelaxations and cyclic adenosine monophosphate elevations that are synergistically enhanced by brain natriuretic peptide in isolated rings of rat thoracic aorta

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 6, 2003, Pages 849-855

  Fung, Erik ^a   Fiscus, Ronald R ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Adenosine monophosphate; Adrenomedullin; Brain natriuretic peptide; Cyclic; Cyclic guanosine monophosphate; Vasorelaxation

Indexed keywords

ADRENOMEDULLIN; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; QUAZINONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ELECTROMYOGRAPHY; ENDOTHELIUM LESION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THORACIC AORTA; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; AORTA, THORACIC; CALCITONIN GENE-RELATED PEPTIDE; CYCLIC AMP; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; MALE; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0038457678     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200306000-00004     Document Type: Article

References (34)

1. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocrine Rev. 2000;21:138-67.
2. Shichiri M, Kato H, Doi M, et al. Induction of Max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol. 1999;13:1353-63.
3. Hattori Y, Nakanishi N, Gross SS, et al. Adrenomedullin augments nitric oxide and tetrahydrobiopterin synthesis in cytokine-stimulated vascular smooth muscle cells. Cardiovasc Res. 1999;44:207-14.
4. Ikeda U, Kanbe T, Shimada K. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1. Hypertension. 1996;27:1240-4.
5. Ishizaka Y, Ishizaka Y, Tanaka M, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994;200:642-6.
6. Eguchi S, Hirata Y, Kano H, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBSLett. 1994;340:226-30.
7. Yoshimoto R, Mitsui-Saito M, Ozaki H, et al. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery. Br J Pharmacol. 1998;123:1645-54.
8. Hayakawa H, Hirata Y, Kakoki M, et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension. 1999;33:689-93.
9. Fiscus R, Zhou HL, Wang X, et al. Calcitonin gene-related peptide (CGRP)-induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are antagonized by blockers of endothelium-derived relaxant factor (EDRF). Neuropeptides. 1991;20:133-43.
10. Wang X, Han C, Fiscus RR. Calcitonin gene-related peptide (CGRP) causes endothelium-dependent cyclic AMP, cyclic GMP and vasorelaxant responses in rat abdominal aorta. Neuropeptides. 1991;20:115-24.
11. Gray DW, Marshall I. Human α-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol. 1992;107:691-6.
12. Fiscus RR, Hao H, Wang X, et al. Nitroglycerin (exogenous nitric oxide) substitutes for endothelium-derived nitric oxide in potentiating vasorelaxations and cyclic AMP elevations induced by calcitonin gene-related peptide (CGRP) in rat aorta. Neuropeptides. 1994;26:133-44.
13. Li Y, Fiscus RR, Wu J, et al. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells. Neuropeptide. 1997;31:503-9.
14. Wang X, Wang W, Li Y, et al. Mechanism of SNAP potentiating antiproliferative effect of calcitonin gene-related peptide in cultured vascular smooth muscle cells. J Mol Cell Cardiol. 1999;31:1599-606.
15. Shimekake Y, Nagata K, Ohta S, et al. Adrenomedullin stimulated two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem. 1995;270:4412-7.
16. Yu CM, Sanderson JE, Shum IO, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure: higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J. 1996;17:1694-702.
17. Zhou HL, Fiscus RR. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Neuropeptides. 1989;14:161-9.
18. Fiscus RR, Rapoport RM, Murad F. Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. J Cycl Nucl Prot Phos Res. 1983;9:415-5.
19. Fiscus RR, Rapoport RM, Waldman SA, et al. Atriopeptin II elevates cyclic GMP, activates cyclic-GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochim Biophys Acta. 1985;846:179-184.
20. Fiscus RR, Murad F. cGMP-dependent protein kinase activation in intact tissues. In: Corbin JD, Johnson RA, eds. Methods of Enzymology: Initiation and Termination of Cyclic Nucleotide Action. San Diego: Academic Press, 1988:150-9.
21. Fiscus RR. Molecular mechanisms of endothelium-mediated vasodilation. Semin Thromb Hemost. 1988;14(suppl):12-22.
22. Maurice DH, Haslam RJ. Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle, Eur J Pharmacol. 1990;191:471-5.
23. Fiscus RR, Lu L, Tu AWK, et al. Brain natriuretic peptide enhances the endothelium-independent cAMP and vasorelaxant responses of calcitonin gene related peptide in rat aorta. Neuropeptides. 1998;32:499-509.
24. Lindgren S, Rascon A, Andersson KE, et al. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterase and relaxation of rat aorta. Biochem Pharmacol. 1991;42:545-52.
25. Lu LF, Fiscus RR. Nitric oxide donors enhance calcitonin gene-related peptide-induced elevations of cyclic AMP in vascular smooth muscle cells. Eur J Pharmacol, 1999;376:307-14.
26. Fiscus RR, Tu AWK, Cheng Chew SB. Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC 12 cells. Neuroreport. 2001;12:185-9.
27. Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988-94.
28. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation. 1996;93:1963-9.
29. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart. 1999;81:483-7.
30. Pousset F, Masson F, Chavirovskaia O, et al. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J. 2000;21:1009-14.
31. Lainchbury JG, Nicholls MG, Espiner EA, et al. Bioactivity and interactions ofadrenomedullin and brain natriuretic peptide in patients with heart failure, Hypertension, 1999;34:70-5.
32. Shindo T, Kurihara H, Maemura K, et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature, Circulation. 2000;101:2309-16.
33. Burnett JC. Vasopeptidase inhibition: a new concept in blood pressure management. J Hypertens Suppl. 1999;17:S37-43.
34. Vanhoutte PM. Say NO to ET. J Auton Nerv Syst. 2000;81:271-7.